Replimune (REPL) Current Assets (2018 - 2026)
Replimune (REPL) reported Current Assets of $324.04 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 2.9% from $333.75 million a year earlier but up 61.4% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune posted Current Assets of $279.12 million, down 43.7% from FY2025.
- Current Assets has a five-year compound annual growth rate of -10.4% (FY2021 to FY2026).
- By fiscal year, Current Assets came in at $495.88 million in FY2025 (+14.3%), $433.67 million in FY2024 (-26.8%), $592.6 million in FY2023 (+46.7%) and $403.98 million in FY2022 (-16.5%).
- Five-year quarterly Current Assets spans a low of $200.81 million in fiscal Q1 2027 and a high of $623.96 million in fiscal Q3 2023.
- Year over year, Current Assets has now declined in each of the last six quarters, with an average decline of 19.6% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was fiscal Q4 2023 (growth of 46.7%); the low point was fiscal Q1 2027 (a decline of 51.4%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $200.81 million (Q1 2027), $279.12 million (Q4 2026) and $280.35 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | 324.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 324.04 Mn |
| Jun 30, 2026 | 200.81 Mn |
| Mar 31, 2026 | 279.12 Mn |
| Dec 31, 2025 | 280.35 Mn |
| Sep 30, 2025 | 333.75 Mn |
| Jun 30, 2025 | 413.37 Mn |
| Mar 31, 2025 | 495.88 Mn |
| Dec 31, 2024 | 547.58 Mn |
| Sep 30, 2024 | 442.64 Mn |
| Jun 30, 2024 | 480.32 Mn |
| Mar 31, 2024 | 433.67 Mn |
| Dec 31, 2023 | 479.16 Mn |
| Sep 30, 2023 | 508.18 Mn |
| Jun 30, 2023 | 550.04 Mn |
| Mar 31, 2023 | 592.60 Mn |
| Dec 31, 2022 | 623.96 Mn |
| Sep 30, 2022 | 379.39 Mn |
| Jun 30, 2022 | 401.95 Mn |
| Mar 31, 2022 | 403.98 Mn |
| Dec 31, 2021 | 427.80 Mn |
API Access
Replimune Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();